HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Clean Sweep For German Rx-To-OTC Switches Of Next-Gen Pain And Cough Treatments

Executive Summary

Germany’s Expert Committee for Prescription has recommended three novel Rx-to-OTC switch applications: analgesics dexibuprofen and ibuprofen/paracetamol single-pill combinations, and cough treatment levodropropizine.

You may also be interested in...



German Marketing Round-Up: Stada VMS Additions, Bayer On-The-Go Aspirin, Pädia Cough Switch

The latest marketing news from Germany's OTC market: Stada extends Eunova VMS line with two launches; Bayer adds on-the-go pain relief option with Aspirin Complex; and Pädia launches levodropropizine-based cough suppressants under its Quimbo brand.

Next Generation OTC Painkillers And Cough Syrup On Cards For German Switch Committee

Rx-to-OTC switches of the painkillers dexibuprofen and single-pill combinations of ibuprofen and paracetamol as well as the cough medicine levodropropizine, all for oral use, will be considered at the next German Expert Committee for Prescription meeting on 13 July.

Hungary Reverse-Switches High-Dose Ibuprofen

OTC ibuprofen products marketed by Sanofi, Mylan and Zambon among those reverse-switched to Rx status by Hungary's drug regulator.

Topics

Latest News
UsernamePublicRestriction

Register

RS151572

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel